Brean Murray Downgrades Human Genome Sciences to Hold, Removes PT

Symbols: HGSI
Share

Brean Murray Carret & Company has downgraded Human Genome Sciences (NASDAQ: HGSI) from Buy to Hold and has removed its $21 price target.


 
 
< Previous
UPDATE: Citi Downgrades Rating to Neutral, Raises PT to $45 on Celanese
Next >
Bank of America Downgrades CH Robinson Worldwide to Neutral, Lowers PO to $77
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust